Risikoen for alvorlig myelotoksicitet og langvarig immunsuppression er øget hos patienter med sygdomsrelateret knoglemarvsinfiltration eller en tidligere myelosuppressiv behandling.
The risk of severe myelotoxicity and long-lasting immunosuppression is increased in patients with a disease-related bone marrow infiltration or a previous myelosuppressive treatment.